Spero Therapeutics (SPRO) EPS (Basic) (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123.21% |
| Dec 31, 2025 | 530.77% |
| Sep 30, 2025 | -333.33% |
| Jun 30, 2025 | 88.00% |
| Mar 31, 2025 | 34.21% |
| Dec 31, 2024 | -18.75% |
| Sep 30, 2024 | 3.03% |
| Jun 30, 2024 | -37.50% |
| Mar 31, 2024 | -124.74% |
| Dec 31, 2023 | 1,716.67% |
| Sep 30, 2023 | 73.91% |
| Jun 30, 2023 | 8.00% |
| Mar 31, 2023 | -126.88% |
| Dec 31, 2022 | 381.82% |
| Sep 30, 2022 | 62.07% |
| Jun 30, 2022 | 13.86% |
| Mar 31, 2022 | -9.78% |
| Dec 31, 2021 | -31.43% |
| Sep 30, 2021 | -11.11% |
| Jun 30, 2021 | 4.55% |
| Mar 31, 2021 | -8.20% |
| Dec 31, 2020 | 29.07% |
| Sep 30, 2020 | -1.18% |
| Jun 30, 2020 | 30.33% |
| Mar 31, 2020 | 6.87% |
| Dec 31, 2019 | -37.89% |
| Sep 30, 2019 | -28.38% |
| Jun 30, 2019 | -155.17% |
| Mar 31, 2019 | 51.67% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 13.04% |
| Jun 30, 2018 | 6.76% |
| Mar 31, 2018 | 53.46% |
| Dec 31, 2017 | 95.59% |
| Sep 30, 2017 | 0.52% |
| Jun 30, 2017 | -67.64% |
| Mar 31, 2017 | 15.89% |
| Dec 31, 2016 | -10.55% |